Olympus Corporation of the Americas
Clinical trials sponsored by Olympus Corporation of the Americas, explained in plain language.
The Americas subsidiary of Olympus, a Japanese company making medical endoscopy and surgical devices.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New lung valve registry aims to improve breathing in severe emphysema Results expected Dec 2026 (estimated)
- New stent aims to ease Cancer-Related bile duct blockages without surgery Results expected Feb 2027 (estimated)
- New Scope-Based ultrasound could spare patients liver biopsies Results expected Feb 2027 (estimated)
- Temporary implant vs permanent: which is safer for BPH? Results expected Jul 2027 (estimated)